Graham M - Search Results

1

NSW Cannabis Medicines Advisory Service preliminary survey results: enquirer perceptions and patient outcomes.

Graham M, Bird S, Howard Z, Dobson M, Palazzi K, Lucas CJ, Schneider J, Eagar K, Martin JH. Graham M, et al. Intern Med J. 2022 Feb;52(2):228-237. doi: 10.1111/imj.15635. Epub 2022 Feb 10. Intern Med J. 2022. PMID: 34837455 Free PMC article.

2

Translational hurdles with cannabis medicines.

Graham M, Lucas CJ, Schneider J, Martin JH, Hall W. Graham M, et al. Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1325-1330. doi: 10.1002/pds.4999. Epub 2020 Apr 12. Pharmacoepidemiol Drug Saf. 2020. PMID: 32281186 Review.

3

Expert advice for prescribing cannabis medicines for patients with epilepsy-drawn from the Australian clinical experience.

Lawson J, O'Brien T, Graham M, Renaud E, Jones D, Freeman J, Lawn N, Martin JH. Lawson J, et al. Among authors: graham m. Br J Clin Pharmacol. 2022 Jul;88(7):3101-3113. doi: 10.1111/bcp.15262. Epub 2022 Mar 8. Br J Clin Pharmacol. 2022. PMID: 35261078 Free PMC article. Review.

4

Cannabidiol drug interaction considerations for prescribers and pharmacists.

Graham M, Martin JH, Lucas CJ, Murnion B, Schneider J. Graham M, et al. Expert Rev Clin Pharmacol. 2022 Dec;15(12):1383-1397. doi: 10.1080/17512433.2022.2142114. Epub 2022 Nov 9. Expert Rev Clin Pharmacol. 2022. PMID: 36317739

5

Medicinal Cannabis Guidance and Resources for Health Professionals to Inform Clinical Decision Making.

Graham M, Renaud E, Lucas CJ, Schneider J, Martin JH. Graham M, et al. Clin Ther. 2023 Jun;45(6):527-534. doi: 10.1016/j.clinthera.2023.03.007. Clin Ther. 2023. PMID: 37414503

6

From growers to patients: Multi-stakeholder views on the use of, and access to medicinal cannabis in Australia.

Erku D, Greenwood LM, Graham M, Hallinan CM, Bartschi JG, Renaud E, Scuffham P. Erku D, et al. Among authors: graham m. PLoS One. 2022 Nov 11;17(11):e0277355. doi: 10.1371/journal.pone.0277355. eCollection 2022. PLoS One. 2022. PMID: 36367871 Free PMC article.

7

A provisional evaluation of Australia's medical cannabis program.

Graham M, Chiu V, Stjepanović D, Hall W. Graham M, et al. Int J Drug Policy. 2023 Dec;122:104210. doi: 10.1016/j.drugpo.2023.104210. Epub 2023 Oct 7. Int J Drug Policy. 2023. PMID: 37813082 Free article.

8

Over the counter low-dose cannabidiol: A viewpoint from the ACRE Capacity Building Group.

Hallinan CM, Eden E, Graham M, Greenwood LM, Mills J, Popat A, Truong L, Bonomo Y. Hallinan CM, et al. Among authors: graham m. J Psychopharmacol. 2022 Jun;36(6):661-665. doi: 10.1177/02698811211035394. Epub 2021 Aug 3. J Psychopharmacol. 2022. PMID: 34344208

9

Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies.

Nielsen S, Picco L, Murnion B, Winters B, Matheson J, Graham M, Campbell G, Parvaresh L, Khor KE, Betz-Stablein B, Farrell M, Lintzeris N, Le Foll B. Nielsen S, et al. Among authors: graham m. Neuropsychopharmacology. 2022 Jun;47(7):1315-1330. doi: 10.1038/s41386-022-01322-4. Epub 2022 Apr 22. Neuropsychopharmacology. 2022. PMID: 35459926 Free PMC article.

10

Avoiding the Premature Introduction of Psychedelic Medicines in Alzheimer's Disease and Related Disorders.

Carter A, Graham M, Hall W, Barber M, Gardner J. Carter A, et al. Among authors: graham m. AJOB Neurosci. 2023 Apr-Jun;14(2):129-131. doi: 10.1080/21507740.2023.2188287. AJOB Neurosci. 2023. PMID: 37097862 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,108 results

Search Page